logo
Select company
Select metric
1.56%Debt to Assets Ratio
VS
Market
85
Sector
77
Industry
69
History
85
$ 2.24Close
$ 1.95 - $ 5.35 52-Week Range
Ticker Information

Ticker

CRDF

Company Name

CARDIFF ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARDIFF ONCOLOGY INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRDF - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 75.74M$ 1.19M1.56%
3/31/2025$ 84.81M$ 1.36M1.6%
12/31/2024$ 97.19M$ 1.52M1.57%
9/30/2024$ 62.9M$ 1.69M2.68%
6/30/2024$ 66.05M$ 1.84M2.79%
3/31/2024$ 74.04M$ 2M2.7%
12/31/2023$ 81.64M$ 2.15M2.63%
9/30/2023$ 88.45M$ 2.29M2.59%
6/30/2023$ 97.45M$ 2.44M2.5%
3/31/2023$ 106.55M$ 2.58M2.42%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARDIFF ONCOLOGY INC's latest trailing twelve months (TTM) Debt to Assets stands at 3.54%.
  • Over the past 5 years, CARDIFF ONCOLOGY INC's average Debt to Assets has been 2.08%.
  • The median Debt to Assets for CARDIFF ONCOLOGY INC during this period was 2.31%
  • CARDIFF ONCOLOGY INC reached its highest Debt to Assets over the past 5 years at 3.54%.
  • The lowest Debt to Assets recorded by CARDIFF ONCOLOGY INC in the same timeframe 0.28%

CARDIFF ONCOLOGY INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
MREO : MEREO BIOPHARMA GROUP PLC 0.96%AVTX : AVALO THERAPEUTICS INC 0%HUMA : HUMACYTE INC 60.28%COYA : COYA THERAPEUTICS INC 0%VTGN : VISTAGEN THERAPEUTICS INC 3.42%ABEO : ABEONA THERAPEUTICS INC 9.78%ABVC : ABVC BIOPHARMA INC 9.76%LYEL : LYELL IMMUNOPHARMA INC 12.09%CURX : CURANEX PHARMACEUTICALS INC 60.53%MNPR : MONOPAR THERAPEUTICS 0.15%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for CARDIFF ONCOLOGY INC is calculated as follows: Debt [ $ 1.4M ] / Assets [ $ 39.45M ]
(=) Debt to Assets [ 3.54% ]

CRDF - Debt to Assets Ratio, Last 5 years

0.28%

Minimum

Jun 30, 2021

3.54%

Maximum

Sep 30, 2020

2.08%

Average

2.31%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.33% with a standard deviation of 24.52%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.38K
min0%
max116.6%
average26.33%
median21.07%
std24.52%